← Back to Search

Housing + Opioid Prevention for Substance Use Disorders (HOME Trial)

N/A

Waitlist Available

Research Sponsored by Ohio State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

ages of 18 to 24 years

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

HOME Trial Summary

This trial will test whether providing housing and opioid prevention services to homeless youth can reduce the likelihood of developing an opioid use disorder.

Who is the study for?

This trial is for young adults aged 18 to 24 who are homeless as defined by the McKinney-Vento Act and do not currently meet the criteria for an Opioid Use Disorder. It aims to engage these individuals in services that could prevent opioid and other drug use.Check my eligibility

What is being tested?

The HOME Project is testing whether providing housing along with risk prevention services can help prevent opioid use disorders among homeless youth, compared to offering only risk prevention services without housing support.See study design

What are the potential side effects?

Since this trial involves social interventions like housing support rather than medical treatments, there aren't typical medication side effects. However, participants may experience stress or anxiety related to changes in their living situation.

HOME Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 24 years old.

HOME Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

change in opioid use

HOME Trial Design

2Treatment groups

Experimental Treatment

Group I: Risk Prevention Services OnlyExperimental Treatment1 Intervention

Opioid and related prevention services including Strengths-Based Outreach and Advocacy (SBOA), MI, HIV risk and suicide prevention (CTSP).

Group II: Risk Prevention Services +HousingExperimental Treatment1 Intervention

Opioid and related prevention services including Strengths-Based Outreach and Advocacy (SBOA), MI, HIV risk and suicide prevention (CTSP) as well as rental and utility assistance for 6 months.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor

828 Previous Clinical Trials

505,511 Total Patients Enrolled

4 Trials studying Substance Abuse

630 Patients Enrolled for Substance Abuse

Nationwide Children's HospitalOTHER

341 Previous Clinical Trials

5,220,263 Total Patients Enrolled

Media Library

Risk Prevention Services + Housing Clinical Trial Eligibility Overview. Trial Name: NCT04135703 — N/A

Substance Abuse Research Study Groups: Risk Prevention Services +Housing, Risk Prevention Services Only

Substance Abuse Clinical Trial 2023: Risk Prevention Services + Housing Highlights & Side Effects. Trial Name: NCT04135703 — N/A

Risk Prevention Services + Housing 2023 Treatment Timeline for Medical Study. Trial Name: NCT04135703 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the expected recruitment rate for this clinical trial?

"Affirmative. Clinicaltrials.gov data confirms that recruitment for this clinical study, which was first advertised on December 1 2019, is still ongoing. There are a total of 240 patients needed from one medical centre."

Answered by AI

Are there any vacancies open to participants in this experiment?

"Affirmative. As evidenced on clinicaltrials.gov, this research project is currently enrolling participants; the trial went live on December 1st 2019 and was most recently modified October 3rd 2022. 240 patients are being sought out from one medical site."

Answered by AI

Is the target demographic for this research restricted to individuals aged 50 and above?

"In line with the qualifications for this clinical study, only participants aged 18-24 will be accepted."

Answered by AI

Who should be considered a prime candidate for this clinical trial?

"The study is open to 240 individuals between 18 and 24 who are dealing with substance misuse. In order for participants to qualify, they must meet the McKinney-Vento definition of homeless, not fit DSM 5 criteria for opioid use disorder as determined by a SCID test, and fall within the age parameters mentioned above."

Answered by AI

Recent research and studies

Addiction Science & Clinical PracticeJournal

Housing, Opportunities, Motivation and Engagement (HOME) for Homeless Youth At-risk for Opioid Use Disorder: Study Protocol for a Randomized Controlled Trial

Slesnick, Natasha, Laura Chavez, Alicia Bunger, Ruri Famelia, Jodi Ford, Xin Feng, Sarah Higgins, et al.. 2021. “Housing, Opportunities, Motivation and Engagement (HOME) for Homeless Youth At-risk for Opioid Use Disorder: Study Protocol for a Randomized Controlled Trial”. Addiction Science & Clinical Practice. Springer Science and Business Media LLC. doi:10.1186/s13722-021-00237-7.

BMC Public HealthJournal

Housing First Combined with Suicide Treatment Education and Prevention (HOME + STEP): Study Protocol for a Randomized Controlled Trial

Chavez, Laura, Kelly Kelleher, Alicia Bunger, Brittany Brackenoff, Ruri Famelia, Jodi Ford, Xin Feng, et al.. 2021. “Housing First Combined with Suicide Treatment Education and Prevention (HOME + STEP): Study Protocol for a Randomized Controlled Trial”. BMC Public Health. Springer Science and Business Media LLC. doi:10.1186/s12889-021-11133-9.

clinicaltrials.govStudy

Prevention of OUD: The HOME Project (Housing, Opportunities, Motivation and Engagement)

Natasha Slesnick 2019. "Prevention of OUD: The HOME Project (Housing, Opportunities, Motivation and Engagement)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04135703.

All > Substance Abuse